This article will discuss: 10 Pro-Life Companies to Invest In Now.

Investing isn’t just about numbers—it’s also about values. As socially responsible investing (SRI) gains traction, a growing segment of investors is looking to align their portfolios with their ethical beliefs. One such approach focuses on pro-life investing, where individuals seek to support companies that reflect their views on life-related policies while aiming for strong financial returns.

The 2022 overturning of Roe v. Wade brought corporate policies on reproductive rights into the spotlight. Some Fortune 250 companies publicly committed to covering travel costs for employees seeking abortions, yet financial disclosures revealed many of these same companies donated millions to lawmakers supporting restrictive abortion laws. This contrast between public messaging and political contributions has fueled a push for greater transparency in corporate decision-making, prompting investors to scrutinize where their money flows.

According to the Sustainable Investments Institute, major U.S. companies and their PACs poured over $515 million into political candidates opposed to reproductive rights over two election cycles. These firms were among those balancing both pro-choice and pro-life initiatives, showcasing the complex and sometimes contradictory nature of corporate influence.

On the other side of the spectrum, values-based investing – sometimes called morally responsible investing (MRI) -has expanded as an alternative for investors who prioritize faith-driven or ethics-based financial decisions. This niche overlaps with broader Environmental, Social, and Governance (ESG) strategies, which aim to integrate social values into investment choices. Within this space, funds like Ave Maria Mutual Funds, Timothy Plan, and GuideStone Funds have carved out a place by offering investment options aligned with specific moral and religious standards.

Ave Maria Mutual Funds, for example, applies a proprietary moral screening process to exclude companies involved in activities deemed inconsistent with its guiding principles. As of December 31, 2024, it managed $3.5 billion in assets, with its Ave Maria Growth Fund delivering a 14.77% return over the past year and a 9.44% return over five years. Similarly, the Timothy Plan, recognized as the oldest values-based mutual fund family, offers investment products that cater to investors seeking alignment with biblical principles. GuideStone Funds integrates a life-focused component into its portfolio, appealing to those who prioritize such considerations in their financial strategies.

For those looking to blend finance with philosophy, pro-life investing represents one of many ways to tailor a portfolio to personal beliefs. Whether an investor is motivated by ethical considerations, political leanings, or financial strategy, the rise of values-based funds suggests a growing demand for options that go beyond traditional profit-driven decision-making. As the investing landscape evolves, the conversation around corporate responsibility and political influence will likely remain a key factor in shaping financial choices. With these points in mind, we look at the pro-life companies to invest in right now.

Our Methodology

To create our list, we focused on the top holdings of the Ave Maria Mutual Funds, which applies a fundamental security analysis filtered through pro-life and pro-family criteria. These screens exclude companies involved in abortion, embryonic stem cell research, Planned Parenthood, and pornography. Beyond moral considerations, the fund focuses on companies with a strong potential for price appreciation. We then ranked these companies according to the highest number of hedge funds ownerships. We have used Insider Monkey’s Q4 2024 exclusive proprietary database of hedge funds to arrive at our rankings.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

10. Permian Basin Royalty Trust (NYSE:PBT)

Number of Hedge Funds: 3

Permian Basin Royalty Trust (NYSE:PBT) is an express trust established in 1980, holding royalty interests in various oil and gas properties across the United States. The trust’s principal assets include a 75% net overriding royalty interest in the Waddell Ranch properties located in Crane County, Texas, and a 95% net overriding royalty interest in other major producing royalty properties throughout Texas. These assets generate revenue primarily from the production and sale of oil and natural gas, positioning Permian Basin Royalty Trust (NYSE:PBT) as a significant player in the energy sector. It is one of the best Pro-Life companies to invest in.

The energy sector has experienced notable changes, particularly in New Mexico, where legislators approved an increase in future oil royalty rates for prime land from 20% to 25%. While this change does not directly affect Permian Basin Royalty Trust (NYSE:PBT)’s Texas-based operations, it reflects a broader trend toward optimizing returns from natural resources, which could influence future regulatory considerations in other states.

As of March 22, 2025, PBT is trading at $10.07, reflecting a slight decrease of 0.98% from the previous close. Permian Basin Royalty Trust (NYSE:PBT) reported a Q3 2024 net income of $8.1 million, with total revenue declining 6.81% year-over-year but stabilizing sequentially. This signals potential recovery if the trend continues. The stock trades near its 52-week low and below its 200-day moving average. Over the past five years, revenue has surged 398.35% to $29.92 million. Despite past gains, analysts recently downgraded PBT from “Buy” to “Hold,” with a $13.00 price target.

9. LandBridge Company LLC (NYSE:LB)

Number of Hedge Funds: 20

LandBridge Company LLC (NYSE:LB) is a Houston-based firm specializing in land and resource management to support and enhance oil and natural gas development in the United States. The company owns extensive surface acreage in and around the Delaware Basin in Texas and New Mexico, holding a portfolio of oil and gas royalties. Additionally, LandBridge generates revenue through the sale of brackish water and other surface composite materials.

Since its initial public offering (IPO) on June 28, 2024, at $17 per share, LandBridge Company LLC (NYSE:LB)’s stock has experienced remarkable growth. The stock closed its debut at $23.15, a 36% premium over the IPO price. As of March 22, 2025, LB is trading at $77.05, reflecting a substantial increase since its IPO. It is among the best Pro-Life companies to invest in.

In its Q4 2024 earnings report, LandBridge Company LLC (NYSE:LB) reported revenues of $36.5 million and a net income of $8 million, marking significant growth. For the full year 2024, the company delivered revenue growth of 109% year-over-year. Looking ahead, LandBridge projects an EBITDA of $170-$190 million for 2025 and anticipates earnings per share (EPS) of $1.70, with expectations of rising to $2.11 in 2026.

On March 21, Barclays issued a Hold rating for LandBridge Company LLC (NYSE:LB), but overall analyst sentiment remains positive. The median price target is $80.00, with a Moderate Buy rating from nine analysts, 67% recommending a Buy.

8. Haemonetics Corp (NYSE:HAE)

Number of Hedge Funds: 28

​Haemonetics Corp (NYSE:HAE) is a global healthcare company specializing in blood management solutions. Its portfolio includes devices, information management systems, and consulting services aimed at optimizing blood and plasma collection, surgical blood salvage, and hospital transfusion services. Haemonetics Corp (NYSE:HAE) operates across various medical markets, providing products for surgical blood salvage, blood component collections, and plasma collections worldwide.

Haemonetics Corp (NYSE:HAE) recently completed the sale of its whole blood assets to GVS S.p.A. in January 2025, enabling the company to focus on high-growth areas within blood management. In March 2025, Haemonetics appointed Frank W. Chan, Ph.D., as Executive Vice President, leveraging his 25+ years of leadership experience in medical devices and healthcare technology to strengthen strategic initiatives. Frank has previously held a key leadership position as President of the Medtronic Acute Care & Monitoring (ACM) business.

Haemonetics Corp (NYSE:HAE) reported a total revenue of $1.31 billion over the past year, reflecting a 12.01% increase, driven by strong sales growth and operational efficiencies. As of March 25, 2025, Haemonetics’ stock trades at $64.45, with a market cap of $3.23 billion. Analysts remain bullish, with 82% of 11 analysts rating it a “Buy” and a median price target of $97.50, suggesting a 51.28% upside potential, as of March 25th.

7. Texas Pacific Land Corporation (NYSE:TPL)

Number of Hedge Funds: 28

Texas Pacific Land Corporation (NYSE:TPL) is one of the largest landowners in Texas, operating primarily through two business segments: Land and Resource Management and Water Services and Operations. The company generates revenue by leasing land for oil and gas exploration, collecting royalties, and providing water sourcing and treatment services, predominantly in the Permian Basin.

In Q4 2024, Texas Pacific Land Corporation (NYSE:TPL) reported a net income of $118.4 million, an increase from $106.6 million in the previous quarter. Total revenues rose to $185.8 million, up from $173.6 million, driven by higher easements and surface-related income, as well as increased oil and gas royalty revenues. The company also achieved a record free cash flow of $461 million for the year, marking an 11% increase from the previous year. ​

In November 2024, Texas Pacific Land Corporation (NYSE:TPL) was added to the S&P index, replacing Marathon Oil. Despite a recent stock price rally, TPL remains approximately 25% below its 52-week high of $1,769.14. The company delivered strong gains of over 260% in the past two years. TPL’s stock has been highlighted for its aggressive upward momentum, reflecting a solid shareholder base and minimal pullbacks.

The average price target for Texas Pacific Land Corporation (NYSE:TPL) stands at $1,300, with analysts maintaining a “Hold” rating on the stock. Institutional investors dominate ownership, holding 71% of the company’s shares. However, a significant number of insider sales might be a cause for caution, with the most recent sale by Michael Dobbs marking the largest sale in TPL’s recent trading activity.

6. TD SYNNEX Corporation (NYSE:SNX)

Number of Hedge Funds: 33

​TD SYNNEX Corporation (NYSE:SNX) is a leading global distributor and solutions aggregator for the IT ecosystem, offering a comprehensive range of products and services. Serving over 150,000 customers in more than 100 countries, the company collaborates with over 2,500 best-in-class technology vendors, positioning itself as a pivotal player in the technology distribution industry. It is one of the best Pro-Life companies to invest in.

TD SYNNEX Corporation (NYSE:SNX) was recognized as the Americas Distributor of the Year by NVIDIA on March 19, highlighting its strong partnerships and industry standing. This is following its receiving major accolades such as the Palo Alto Networks 2024 Global Distributor of the Year and North American Distributor of the Year Awards. Additionally, the company is scheduled to announce its first-quarter fiscal 2025 results on March 27, 2025, providing insights into its financial performance and strategic direction.

Analyst sentiment toward TD SYNNEX Corporation (NYSE:SNX) remains positive. As of March 22, 2025, analysts have set a 12-month average price target of $150.00 for the stock, with estimates ranging from a low of $145.00 to a high of $165.00. Out of 13 analyst ratings, 77% have rated a Buy for the stock.

The company’s revenue guidance for the first quarter of 2025 is between $14.4 billion and $15.2 billion, with an expected earnings per share (EPS) ranging from $2.65 to $3.15.

5. Wheaton Precious Metals Corp. (NYSE:WPM)

Number of Hedge Funds: 36

​Wheaton Precious Metals Corp. (NYSE:WPM) is a leading Canadian precious metal streaming company. Unlike traditional mining firms, Wheaton provides upfront financing to mining companies in exchange for the right to purchase a percentage of their future silver and gold production at predetermined prices. The unique business model allows Wheaton to offer investors exposure to precious metals without the operational risks associated with mining activities.

In 2024, ​Wheaton Precious Metals Corp. (NYSE:WPM) reported record financial performance, achieving revenues of $1.24 billion, adjusted net earnings of $653 million, and operating cash flow of $876 million. The company exceeded its 2024 production guidance, delivering over 633,000 gold equivalent ounces (GEOs), surpassing the upper end of its projected range. Looking ahead, Wheaton has set a 2025 production guidance between 600,000 and 670,000 GEOs and forecasts a substantial growth of approximately 40%, aiming to reach 870,000 GEOs by 2029. It is among the best Pro-Life companies to invest in.

​Wheaton Precious Metals Corp. (NYSE:WPM) announced an increase in its first quarterly cash dividend for 2025 to $0.165 per common share, representing a 6.5% increase from the previous quarter’s $0.155.

As of March 22, 2025, Wheaton’s stock is trading at $75.00 per share, with an intraday high of $75.48 and a low of $73.73. The stock has experienced a slight decrease of 0.74% from the previous close, reflecting the broader market trends.

Wheaton Precious Metals Corp. (NYSE:WPM) holds a strong Buy rating from 94% of 16 analysts, with a median price target of $78.00, indicating a potential 3.97% upside.

4. Brown & Brown, Inc. (NYSE:BRO)

Number of Hedge Funds: 39

​Brown & Brown, Inc. (NYSE:BRO) is a prominent insurance brokerage firm offering a comprehensive range of risk management solutions, including property, casualty, and employee benefits insurance products. The company serves a diverse clientele, encompassing businesses, public entities, individuals, and trade associations.

In Q4 of 2024, Brown & Brown, Inc. (NYSE:BRO) reported total revenues of $1.2 billion, marking a 15.4% increase from the previous year. This growth was driven by a 13.8% rise in organic revenue, while total revenue increased 12.87% since last year. In January 2025, the company declared a quarterly cash dividend of $0.15 per share. Additionally, Brown & Brown’s total assets increased to $17.6 billion as of December 31, 2024, up from $14.9 billion at the end of 2023.

Over the past year, Brown & Brown, Inc. (NYSE:BRO) stock has surged approximately 43.5%, reaching near 52-week highs. Analysts maintain a positive outlook, with a consensus price target of $118.00.

Brown & Brown, Inc. (NYSE:BRO) maintains strong institutional backing, with 77.50% of its shares held by institutional investors, reflecting confidence in its long-term growth potential.

3. Mirion Technologies, Inc. (NYSE:MIR)

Number of Hedge Funds: 43

Mirion Technologies, Inc. (NYSE:MIR) is a global leader in radiation detection, measurement, analysis, and monitoring solutions, serving diverse sectors such as nuclear energy, defense, medical, and scientific research. The company’s product portfolio includes dosimeters, contamination and clearance monitors, and radiation monitoring systems, all designed to ensure safety and operational efficiency in environments where ionizing radiation is present.

In Q4 2024, Mirion Technologies, Inc. (NYSE:MIR) reported record financial performance, with revenues increasing by 10.4% to $254.3 million compared to the same period in 2023. The company achieved a GAAP net income of $15.9 million, a significant turnaround from the $14.5 million net loss in the prior year’s quarter. Adjusted EBITDA also saw a 14.1% rise, reaching $69.6 million.

Mirion Technologies, Inc. (NYSE:MIR) has reaffirmed its guidance, anticipating total revenue growth between 4.0% and 6.0%, with organic revenue growth projected at 5.5% to 7.5%. The company also expects adjusted EBITDA to range from $215 million to $230 million and adjusted earnings per share between $0.45 and $0.50.

Analysts have taken note of Mirion’s strong performance and future potential. Analysts predict a price target of $20 from five ratings, all of which hold a Buy rating for the stock. Mirion Technologies, Inc. (NYSE:MIR) recently joined the Nuclear Energy Institute (NEI) and strengthened its partnership with the American Nuclear Society (ANS), which are two major nuclear industry organizations. However, insider selling has drawn attention, with Group President Loic Eloy selling $787K worth of shares at $17.89 each over the past year. Despite this, institutional investors hold 89.87% of shares, reflecting strong market confidence.

2. CDW Corporation (NASDAQ:CDW)

Number of Hedge Funds: 46

CDW Corporation (NASDAQ:CDW) is a leading multi-brand provider of information technology solutions, serving business, government, education, and healthcare customers across the United States, the United Kingdom, and Canada. The company’s offerings encompass hardware, software, and integrated IT solutions, including security, cloud, hybrid infrastructure, and digital experience services.

In Q4 2024, CDW Corporation (NASDAQ:CDW) reported net sales of $5.186 billion, reflecting a decline compared to the previous year’s $5.522 billion. Despite this, the company achieved a gross profit of $1.155 billion, maintaining a consistent gross profit margin of 21.8% year-over-year. The total revenue for 2024 stood at $21.00 billion.

CDW Corporation (NASDAQ:CDW) is forecasted to grow its earnings and revenue by 6.5% and 4.1% per annum, respectively. The company’s EPS is expected to increase by 6.5% annually, with a projected return on equity of 69.4% over the next three years. It is among the best Pro-Life companies to invest in.

CDW Corporation (NASDAQ:CDW) reported an EBITDA of $1.95 billion. According to analyst consensus, 57% of 14 analysts have given the stock a “Buy” rating. The median price target stands at $225.00, indicating a potential upside of 35.89%. Additionally, institutional investors hold approximately 96.5% of the company’s outstanding shares.

1. Expand Energy Corporation (NASDAQ:EXE)

Number of Hedge Funds: 71

​Expand Energy Corporation (NASDAQ:EXE) is the largest natural gas producer in the United States, formed in October 2024 through the $7.4 billion all-stock merger of Chesapeake Energy and Southwestern Energy. The company focuses on the acquisition, exploration, and development of oil, natural gas, and natural gas liquids, serving customers across the U.S. ​

Recently, the company approved a new $1 billion share buyback program and increased annual cost-saving estimates from the merger by 25% to $500 million. Additionally, ​Expand Energy Corporation (NASDAQ:EXE) announced the expiration and results of its tender offer for 5.500% Senior Notes due 2026 as part of its ongoing financial optimization efforts.

​Expand Energy Corporation (NASDAQ:EXE) is committed to achieving net-zero emissions by 2035, investing in emissions reduction projects and low-carbon solutions to reach this goal. The company upholds its Human Rights Policy through a dedicated Board’s ESG Committee oversight complying with a focus on federal and local law compliance and indigenous rights.

Stephens & Co. upgraded ​Expand Energy Corporation (NASDAQ:EXE) to Overweight on March 18, 2025, signaling increased confidence in the stock. Among 31 analysts, 77% rate EXE as a Buy, with a median price target of $123.00—implying a 14.58% upside as of March 24. The stock is trading near its 52-week high and remains above its 200-day simple moving average, indicating strong price momentum.

Overall, Expand Energy Corporation (NASDAQ:EXE) ranks first on our list of the pro-life companies to invest in now. While we acknowledge the potential for EXE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than EXE that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.